Hyperthyroidism in Graves' disease - Does a therapeutic standard exist? Antithyroid drug treatment;Hyperthyreose typ morbus basedow - Gibt es einen therapeutischen Standard? Konservative Therapie

Zentralblatt fur Chirurgie

Volumn 122, Issue 4, 1997, Pages 224-226

  Schumm Draeger, P M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

antithyroid drug treatment; Graves' disease; hyperthyroidism; relapse; remission; TSH receptor antibodies

Indexed keywords

CARBIMAZOLE; PROPYLTHIOURACIL; THIAMAZOLE; THYROID HORMONE;

ARTICLE; DRUG EFFICACY; FOLLOW UP; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; RECURRENT DISEASE; STANDARDIZATION;

ANTITHYROID AGENTS; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; LONG-TERM CARE; RECURRENCE; THYROID FUNCTION TESTS;

EID: 0030988016     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Allanic H, Fauchet R, Orgiazzi J., Madec A M, Genetet B, Lorcy Y, Le Guerrier A M, Delambre C, Derennes V (1990) Antithyroid drugs and Graves' disease. A prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab 70: 675-679
2. Edmonds C J, Tellez M (1994) Treatment of Graves' disease by carbimazole: High dose with thyroxine compared to titration dose. Eur J Endocrinol 131: 120-124
3. Feldt-Rasmussen U, Schleusener H, Carayon P (1994) Meta-Analysis: Evaluation of the Impact of Thyrotropin Receptor Antibodies on Long Term Remission after Medical Therapy of Graves' disease. J Clin Endocrinol Metab 78: 98-102
4. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T (1991) Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating receptors and on the risk of recurrence of hyperthyroidism. N Engl J Med 324: 947-953
5. Meng W, Meng S, Männchen E, Harnpel R, Kirsch, Dannenberg G J, Krabbe S (1991) Effect of therapy duration and low and highly dosed thiamazole treatment in Basedow's-Graves' disease. Exp Clin Endocrinol 97: 257-260
6. Reinwein D, Benker G, Alexander W D, Lazarus J H and the European multicenter study group of antithyroid drug treatment (1993 ) A prospective randomized trial of antithyroid drug dose in Graves' disease therapy. J Clin Endocrinol Metab 76: 1516-1521
7. Schleusener H, Schwander J, Fischer C, Holle R, Holl G, Ba-denhoop K, Hensen J, Finke R, Bogner U, Mayr W R, Schernthaner G, Schatz H, Pickardt C R, Kotulla P (1989) Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease. Acta Endocrinol 120: 689-701.